Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by consultant99on Oct 03, 2022 3:58pm
288 Views
Post# 35002402

Another Financing - Seriously?

Another Financing - Seriously? Giving away more shares at 0.25 plus warrants.

Exactly how does this instill confidence for new investors that the company is on the cusp of getting BTD and a positive vaccine animal trial? 

Every time the stock starts to move higher - whack! We were over 0.36 when the first round of the latest financing started. To go back-to-back is just cruel.and now the share price is sitting at 0.24/share. 

If you value the warrants at roughly half the share price I suppose we could see the price drop to 0.17 if existing shareholders are liquidating to participate.
I don't think that will happen or at least I hope not.

I wonder if insiders will participate in the second financing as well...
<< Previous
Bullboard Posts
Next >>